Table 2.

Patients' characteristics and descriptive statistics according to NCCN Guidelines risk classes after definitive therapy

Risk classes
VariableLowIntermediateHighFP
Patients, n (%)251 (34.7)318 (43.9)155 (21.4)
Age, y4.70.09
 Mean (median)63.5 (63.5)64.4 (64.8)68.5 (66.4)
 Range50.6–80.041.4–82.344.8–82.0
BMI, kg/m20.370.69
 Mean (median)26.2 (26.1)26.3 (26.0)26.0 (25.6)
 Range20.0–40.119.5–39.417.3–41.2
tT, ng/mL3.780.023
 Mean (median)4.4 (4.2)4.5 (4.5)3.9 (3.9)
 Range0.0–10.60.0–13.00.0–13.6
tT <3 ng/mL, n (%)46 (18.3)70 (22.0)61 (39.4)2, 24.76)<0.001
E2, pg/mL4.850.008
 Mean (median)33.0 (32.0)34.3 (33.2)30.5 (28.0)
 Range1.0–71.08.0–89.13.0–77.0
tT/E2 ratio5.350.005
 Mean (median)0.14 (0.14)0.13 (0.13)0.12 (0.12)
 Range0.01–0.50.0–0.60.0–0.3
SHBG, nmol/L2.220.69
 Mean (median)35.0 (34.0)37.0 (34.0)39.0 (36.0)
 Range6.0–106.07.0–115.011.0–132.0

NOTE: P value according to ANOVA or χ2 test, as indicated.